Ipratropium Bromide And Albuterol Sulfate
Product Images NDC 55154-2133

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 55154-2133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
An instructional diagram showing a nebulizer device being filled with medication from a vial or ampule. The image depicts the attachment of the nebulizer mouthpiece to the medication chamber.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
An instructional diagram showing a close-up of a hand holding a spray pump bottle with the nozzle facing right, and a separate dropper or tube positioned near the nozzle tip, illustrating how to apply or assemble the spray mechanism.*
FDA Label Image

Figures 3 And 4 (Image 03)

Figures 3 And 4 (Image 03)
Two black and white illustrations show the proper use of a metered-dose inhaler. The first depicts a person placing the inhaler mouthpiece in the mouth, and the second demonstrates the use of a spacer device attached to the inhaler for inhalation.*
FDA Label Image

Bag Label (Image 04)

Bag Label (Image 04)
Label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, 0.5 mg/3 mg per 3 mL. The package contains 5 sterile unit-dose vials, each in a foil pouch. Labeler is Cardinal Health 107, LLC. Instructions for storage, usage, and warnings for oral inhalation use are included.*
FDA Label Image

Chemical Structure (Ipratropium 01)

Chemical Structure (Ipratropium 01)
Chemical structure diagram of Ipratropium bromide with sulfate and albuterol sulfate components, depicting the molecular arrangement as part of the combination drug Ipratropium Bromide and Albuterol Sulfate.*
FDA Label Image

Chemical Structure (Ipratropium 02)

Chemical Structure (Ipratropium 02)
Chemical structure of Ipratropium bromide, showing the molecular arrangement with a bromide hydrate ion (Br- ยท H2O) alongside the main compound.*
FDA Label Image

Figure (Ipratropium 03)

Figure (Ipratropium 03)
Line graph depicting lung function over time in liters on the y-axis versus hours after dosing on the x-axis. It compares Albuterol alone, Ipratropium alone, and the combination of Ipratropium Bromide and Albuterol Sulfate, showing changes from 0 to 8 hours post-dose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.